Schedule 13D ownership disclosure
ArTara Therapeutics Inc
Security class unavailable · CUSIP: 04300J107
Event date: 2020-01-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000905718-20-000062
- Form type
- SC 13D
- Filer
- Abingworth LLP
- CIK
- CIK 1397144
- Filed
- Jan 17, 2020
- Reporting period
- Jan 09, 2020
- Description
- Schedule 13D beneficial ownership